Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$40.65 - $65.76 $747,512 - $1.21 Million
18,389 New
18,389 $882,000
Q3 2023

Nov 14, 2023

SELL
$54.2 - $71.67 $2.07 Million - $2.73 Million
-38,138 Reduced 42.34%
51,931 $3.4 Million
Q2 2023

Aug 14, 2023

SELL
$56.23 - $71.17 $13,888 - $17,578
-247 Reduced 0.27%
90,069 $5.24 Million
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $1.28 Million - $1.63 Million
23,912 Added 36.01%
90,316 $5.58 Million
Q4 2022

Feb 14, 2023

SELL
$61.23 - $83.62 $1.58 Million - $2.15 Million
-25,750 Reduced 27.94%
66,404 $4.22 Million
Q3 2022

Nov 14, 2022

BUY
$65.58 - $84.69 $154,768 - $199,868
2,360 Added 2.63%
92,154 $6.69 Million
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $3.02 Million - $5.44 Million
58,005 Added 182.47%
89,794 $6.11 Million
Q1 2022

May 16, 2022

SELL
$64.92 - $99.47 $5.18 Million - $7.93 Million
-79,735 Reduced 71.5%
31,789 $2.88 Million
Q4 2021

Feb 14, 2022

SELL
$76.51 - $93.96 $8.06 Million - $9.9 Million
-105,373 Reduced 48.58%
111,524 $10.2 Million
Q3 2021

Nov 15, 2021

SELL
$71.29 - $95.99 $454,830 - $612,416
-6,380 Reduced 2.86%
216,897 $17.6 Million
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $55,415 - $79,935
696 Added 0.31%
223,277 $20.8 Million
Q1 2021

May 17, 2021

BUY
$77.91 - $125.92 $1.57 Million - $2.54 Million
20,145 Added 9.95%
222,581 $23.8 Million
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $3.52 Million - $5.13 Million
58,737 Added 40.88%
202,436 $17.7 Million
Q3 2020

Nov 16, 2020

SELL
$47.53 - $82.76 $2.82 Million - $4.92 Million
-59,424 Reduced 29.26%
143,699 $9.92 Million
Q2 2020

Aug 14, 2020

BUY
$42.51 - $52.46 $8.63 Million - $10.7 Million
203,123 New
203,123 $9.84 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.2B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.